Annual Working Capital
$107.06 M
+$41.36 M+62.95%
31 December 2023
Summary:
Lexeo Therapeutics Common Stock annual working capital is currently $107.06 million, with the most recent change of +$41.36 million (+62.95%) on 31 December 2023. During the last 3 years, it has risen by +$78.35 million (+272.90%). LXEO annual working capital is now -17.16% below its all-time high of $129.24 million, reached on 31 December 2021.LXEO Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Working Capital
$132.64 M
-$25.63 M-16.19%
30 September 2024
Summary:
Lexeo Therapeutics Common Stock quarterly working capital is currently $132.64 million, with the most recent change of -$25.63 million (-16.19%) on 30 September 2024. Over the past year, it has increased by +$116.80 million (+737.43%). LXEO quarterly working capital is now -24.83% below its all-time high of $176.46 million, reached on 31 March 2024.LXEO Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LXEO Working Capital Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +63.0% | +737.4% |
| 3 y3 years | +272.9% | - |
| 5 y5 years | - | - |
LXEO Working Capital High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -17.2% | +272.9% | -24.8% | +737.4% |
| 5 y | 5 years | -17.2% | +272.9% | -24.8% | +737.4% |
| alltime | all time | -17.2% | +272.9% | -24.8% | +737.4% |
Lexeo Therapeutics Common Stock Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $132.64 M(-16.2%) |
| June 2024 | - | $158.27 M(-10.3%) |
| Mar 2024 | - | $176.46 M(+64.8%) |
| Dec 2023 | $107.06 M | $107.06 M(+575.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2023 | - | $15.84 M(-54.8%) |
| June 2023 | - | $35.05 M(-46.6%) |
| Dec 2022 | $65.70 M(-49.2%) | $65.70 M |
| Dec 2021 | $129.24 M(+350.2%) | - |
| Dec 2020 | $28.71 M | - |
FAQ
- What is Lexeo Therapeutics Common Stock annual working capital?
- What is the all time high annual working capital for Lexeo Therapeutics Common Stock?
- What is Lexeo Therapeutics Common Stock annual working capital year-on-year change?
- What is Lexeo Therapeutics Common Stock quarterly working capital?
- What is the all time high quarterly working capital for Lexeo Therapeutics Common Stock?
- What is Lexeo Therapeutics Common Stock quarterly working capital year-on-year change?
What is Lexeo Therapeutics Common Stock annual working capital?
The current annual working capital of LXEO is $107.06 M
What is the all time high annual working capital for Lexeo Therapeutics Common Stock?
Lexeo Therapeutics Common Stock all-time high annual working capital is $129.24 M
What is Lexeo Therapeutics Common Stock annual working capital year-on-year change?
Over the past year, LXEO annual working capital has changed by +$41.36 M (+62.95%)
What is Lexeo Therapeutics Common Stock quarterly working capital?
The current quarterly working capital of LXEO is $132.64 M
What is the all time high quarterly working capital for Lexeo Therapeutics Common Stock?
Lexeo Therapeutics Common Stock all-time high quarterly working capital is $176.46 M
What is Lexeo Therapeutics Common Stock quarterly working capital year-on-year change?
Over the past year, LXEO quarterly working capital has changed by +$116.80 M (+737.43%)